Accretion Nutraveda IPO

Incorporated in 2021, Accretion Nutraveda Limited is a healthcare-focused company that deals in contract manufacturing of Ayurvedic and Nutraceutical products. The company is engaged in the manufacture of products in various dosage forms such as tablets, capsules, oral liquids, traditional Ayurvedic powders, medicated oils, and external preparations. The products cover a wide range of therapeutic categories like liver care, women's health, bone and joint support, respiratory health, digestive health, and brain function. The company has a leased factory at Sanand, Ahmedabad, with a total built-up area of around 10,763 sq. ft. spread over two floors.

The company serves domestic as well as export markets in various countries like Sri Lanka, Singapore and the USA by offering a diverse range of dosage forms, leveraging both classical ayurvedic principles and modern nutraceutical science. The company runs its business through two main segments: Domestic sales/Merchant exports (on a loan license basis) and direct exports. The domestic and merchant export segment contributes over 96% of total revenue, while direct exports accounted for 3.38% in FY25.

Geographically, Gujarat accounts for a major part of the revenue at 92.34% in FY25, followed by Maharashtra at 4.23%. Product-wise, external preparations accounted for 22.93% of the revenue in FY25, and the other contributors were tablets at 23.33%, capsules at 20.36%, oral powders at 19.69%, and oral liquids at 11.97%. Meanwhile, revenue contribution from the top 5 customers stands at 75.71%.